4.7 Article

Broccoli sprout beverage is safe for thyroid hormonal and autoimmune status: Results of a 12-week randomized trial

Journal

FOOD AND CHEMICAL TOXICOLOGY
Volume 126, Issue -, Pages 1-6

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.fct.2019.02.004

Keywords

Nrf2; Thyroid; Sulforaphane; Glucoraphanin; Broccoli sprout beverage; Clinical trial

Funding

  1. National Institutes of Health [P01 ES006052, R35 CA197222]
  2. Short Term Scientific Mission by European Cooperation in Science and Technology Action NutRedOx - Personalized nutrition in aging society: redox control of major age - related diseases [CA16112]
  3. Marie Curie ADIPONRF2 (7th European Community Framework Programme) [PIOF-GA-2012-329442]
  4. Swiss National Science Fund SNF-COST projects [C15.0045-174626, IZCOZO-177070]
  5. Swiss National Science Fund [31003A_182105]
  6. Swiss Society for Endocrinology-Diabetology 2014 Young Independent Investigator Award
  7. Leenaards Foundation 2016 Fellowship for Academic Promotion in Clinical Medicine

Ask authors/readers for more resources

Sulforaphane is a redox active natural product present in cruciferous vegetables like broccoli. Broccoli sproutderived products are promising agents for the prevention of oxidative stress-related diseases, but some have long been suspected of thyroidal toxicity. Recent findings also raise the possibility that long-term exposure to sulforaphane, or to other natural substances or drugs that modulate the activity of the transcription factor Nrf2 (NFE2-related factor 2) may lead to thyroid dysfunction or thyroid autoimmune disease, questioning the safety of trials with sulforaphane-containing products. Previous studies addressing possible effects of sulforaphanerelated compounds from natural product extracts on the thyroid were quite short and/or inconsistent. To investigate whether long-term exposure to a beverage enriched with sulforaphane and its precursor glucoraphanin may affect thyroid function, we analyzed biochemical measures of thyroid function and thyroid autoimmunity in 45 female participants in a randomized clinical trial at baseline and after 84 days of beverage administration. Serum levels of thyroid-stimulating hormone, free thyroxine and thyroglobulin were not affected by the treatment, and neither was the thyroid autoimmunity status of participants. These results provide evidence in favor of the safety of chemoprevention strategies that target the activation of Nrf2 to protect against environmental exposures and other oxidative stress-related pathologies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available